Sugi Predict

Sugi Predict / Compounds / SCHEMBL1665360

SCHEMBL1665360

SCHEMBL1665360

CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)CCC(=O)O[C@@H]1C[C@H](C)CC[C@H]1C(C)C

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP19A1 P11511 2/20 0.61
▸ EPHX1 P07099 3/20 0.57
▸ ALDH1A1 P00352 8/20 0.54
▸ TSHR P16473 2/20 0.53
▸ MAPT P10636 2/20 0.53
▸ LMNA P02545 2/20 0.53
▸ NPSR1 Q6W5P4 2/20 0.53
▸ USP2 O75604 1/20 0.53
▸ HPGD P15428 2/20 0.52
▸ MEN1 O00255 2/20 0.52
▸ KMT2A Q03164 2/20 0.52
▸ MAPK1 P28482 2/20 0.51
▸ KDM4E B2RXH2 1/20 0.51
▸ GAA P10253 1/20 0.51
▸ NPC1 O15118 1/20 0.47
▸ MITF O75030 1/20 0.47
▸ TP53 P04637 1/20 0.47
▸ HTT P42858 1/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7998364 1.00 CYP19A1 (0.61) CYP19A1EPHX1ALDH1A1TSHRMAPT
SCHEMBL7998362 1.00 CYP19A1 (0.61) CYP19A1EPHX1ALDH1A1TSHRMAPT
SCHEMBL3397274 1.00 CYP19A1 (0.61) CYP19A1EPHX1ALDH1A1TSHRMAPT
SCHEMBL7991614 1.00 CYP19A1 (0.61) CYP19A1EPHX1ALDH1A1TSHRMAPT
SCHEMBL7991612 1.00 CYP19A1 (0.61) CYP19A1EPHX1ALDH1A1TSHRMAPT
SCHEMBL5712935 1.00 CYP19A1 (0.61) CYP19A1EPHX1ALDH1A1TSHRMAPT
SCHEMBL23255563 1.00 CYP19A1 (0.61) CYP19A1EPHX1ALDH1A1TSHRMAPT
SCHEMBL3424391 1.00 CYP19A1 (0.61) CYP19A1EPHX1ALDH1A1TSHRMAPT
SCHEMBL21610695 1.00 CYP19A1 (0.61) CYP19A1EPHX1ALDH1A1TSHRMAPT
SCHEMBL79841 1.00 CYP19A1 (0.61) CYP19A1EPHX1ALDH1A1TSHRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109661180-A Composition and production and preparation method thereof for sports achievement 西雅图咖米公司 2019-04-19 — — CN claimed
CN-109640704-A Composition and production and preparation method thereof for postexercise recovery 西雅图咖米公司 2019-04-16 — — CN claimed
CN-109640705-A Mineral composition and its preparation and application 西雅图咖米公司 2019-04-16 — — CN claimed
CN-109640703-A Composition and production and preparation method thereof for mental alertness 西雅图咖米公司 2019-04-16 — — CN claimed
CN-109561727-A Health control composition and its preparation and application 西雅图咖米公司 2019-04-02 — — CN claimed
CN-107382931-A A kind of menthol flavor precursor compound and preparation method and application 云南中烟工业有限责任公司 2017-11-24 — — CN claimed
CN-115558126-B Dynamically crosslinked hyaluronic acid hydrogel 海诺生物科技有限公司 2024-11-15 — — CN disclosed
US-11655243-B2 Pyridine and pyrazine derivatives as preferential cannabinoid 2 agonists HOFFMANN-LA ROCHE INC. (US) 2023-05-23 — — US disclosed
US-11655243-B2 Pyridine and pyrazine derivatives as preferential cannabinoid 2 agonists HOFFMANN-LA ROCHE INC. (US) 2023-05-23 — — US disclosed
EP-3995155-A1 RADIOLABELED CANNABINOID RECEPTOR 2 LIGAND F. Hoffmann-La Roche AG (CH) 2022-05-11 — — EP disclosed
WO-2021140683-A1 COOLING SENSATION AGENT COMPOSITION 株式会社タフリーインターナショナル 2021-07-15 — — WO disclosed
US-20210115012-A1 RADIOLABELED CANNABINOID RECEPTOR 2 LIGAND HOFFMANN-LA ROCHE INC. (US) 2021-04-22 — — US disclosed
US-20210115027-A1 PYRIDINE AND PYRAZINE DERIVATIVES AS PREFERENTIAL CANNABINOID 2 AGONISTS HOFFMANN-LA ROCHE INC. (US) 2021-04-22 — — US disclosed
US-20060110442-A1 Coated sherical seamless filled capsules SYMRISE GMBH & CO. KG (DE) 2006-05-25 — — US disclosed
WO-2005077521-A1 COATED SHERICAL SEAMLESS FILLED CAPSULES SYMRISE GMBH & CO. KG (DE) 2005-08-25 — — WO disclosed
US-6506368-B2 Encapsulating a mixture of a lipophilic core material and an oil-soluble dye, wherein said dye is D&C Green No. 6 or guaizulene or mixture of two dyes HAARMANN & REIMBER GMBH (DE) 2003-01-14 — — US disclosed
US-20020159957-A1 Process for producing blue microcapsules SYMRISE AG (DE) 2002-10-31 — — US disclosed
US-4178458-A COOLING ACTION ON SKIN PHILIP MORRIS, INC. (US) 1979-12-11 — — US disclosed
US-4141906-A 2,2-DIMETHYL-3-HYDROXY-3-(3',4'-METHYLENEDIOXYPHENYL-) PROPIONIC ACID OR ITS ETHYL ESTER PHILIP MORRIS INCORPORATED (US) 1979-02-27 — — US disclosed
US-4036237-A Smoking composition PHILIP MORRIS INCORPORATED (US) 1977-07-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210115027-A1 PYRIDINE AND PYRAZINE DERIVATIVES AS PREFERENTIAL CANNABINOID 2 AGONISTS CNR2, CNR1, TBXA2R CYP19A1 812/4885EPHX1 1196/4885ALDH1A1 1342/4885
US-20210115012-A1 RADIOLABELED CANNABINOID RECEPTOR 2 LIGAND CNR1, CNR2, GPR18 CYP19A1 668/4885EPHX1 1251/4885ALDH1A1 1913/4885
US-11655243-B2 Pyridine and pyrazine derivatives as preferential cannabinoid 2 agonists CNR2, CNR1, TBXA2R CYP19A1 812/4885EPHX1 1196/4885ALDH1A1 1342/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.